140 related articles for article (PubMed ID: 9462543)
1. Plasma soluble interleukin-2 receptor levels in patients with idiopathic thrombocytopenic purpura.
Erduran E; Aslan Y; Aliyazicioglu Y; Mocan H; Gedik Y
Am J Hematol; 1998 Feb; 57(2):119-23. PubMed ID: 9462543
[TBL] [Abstract][Full Text] [Related]
2. [Plasma soluble interleukin-2 receptor level in patients with idiopathic thrombocytopenic purpura and its clinical significance].
Ren DQ; Li ZC; Guo C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Aug; 10(4):337-9. PubMed ID: 12513769
[TBL] [Abstract][Full Text] [Related]
3. Treatment of childhood acute immune thrombocytopenic purpura with high-dose methylprednisolone, intravenous immunoglobulin, or the combination of both.
Gereige RS; Barrios NJ
P R Health Sci J; 2000 Mar; 19(1):15-8. PubMed ID: 10761200
[TBL] [Abstract][Full Text] [Related]
4. Soluble P-selectin, interleukin 6, and thrombopoietin levels in children with acute and chronic idiopathic thrombocytopenic purpura and their relationship with mega-dose methylprednisolone therapy: a pilot study.
Olcay L; Yenicesu I; Yetgin S
J Pediatr Hematol Oncol; 2002 Dec; 24(9):742-5. PubMed ID: 12468916
[TBL] [Abstract][Full Text] [Related]
5. [Detection of interleukin-2 receptor in patients with idiopathic thrombocytopenic purpura].
Tan B; Zhao X; Yin C
Hunan Yi Ke Da Xue Xue Bao; 1998; 23(2):191-3. PubMed ID: 10681844
[TBL] [Abstract][Full Text] [Related]
6. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura.
Erduran E; Aslan Y; Gedik Y; Orhan F
Turk J Pediatr; 2003; 45(4):295-300. PubMed ID: 14768792
[TBL] [Abstract][Full Text] [Related]
7. Reduced bone mineral density in childhood chronic idiopathic thrombocytopenic purpura treated with high-dose methylprednisolone.
Dilber C; Dagdemir A; Albayrak D; Albayrak S; Kalayci AG; Aliyazicioglu Y; Basoglu T
Bone; 2004 Jul; 35(1):306-11. PubMed ID: 15207771
[TBL] [Abstract][Full Text] [Related]
8. Clinical features, treatment responses, and outcome of children with idiopathic thrombocytopenic purpura.
Demircioğlu F; Saygi M; Yilmaz S; Oren H; Irken G
Pediatr Hematol Oncol; 2009; 26(7):526-32. PubMed ID: 19863209
[TBL] [Abstract][Full Text] [Related]
9. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
10. Relation between 3435C>T multidrug resistance 1 gene polymorphism with high dose methylprednisolone treatment of childhood acute idiopathic thrombocytopenic purpura.
Akin M; Turgut S; Ayada C; Polat Y; Balci YI; Erdoğan F
Gene; 2011 Nov; 487(1):80-3. PubMed ID: 21718764
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic thrombocytopenic purpura in Egyptian children.
Khalifa AS; Tolba KA; el-Alfy MS; Gadallah M; Ibrahim FH
Acta Haematol; 1993; 90(3):125-9. PubMed ID: 8291370
[TBL] [Abstract][Full Text] [Related]
12. Effects of high-dose methylprednisolone therapy on coagulation factors in patients with acute immune thrombocytopenic purpura.
Oner AF; Bay A; Kuru M; Uner A; Arslan S; Caksen H
Clin Appl Thromb Hemost; 2005 Oct; 11(4):489-92. PubMed ID: 16244777
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of high-dose methylprednisolone versus intravenous immunoglobulin for the treatment of acute idiopathic thrombocytopenic purpura in children.
Ancona KG; Parker RI; Atlas MP; Prakash D
J Pediatr Hematol Oncol; 2002 Oct; 24(7):540-4. PubMed ID: 12368690
[TBL] [Abstract][Full Text] [Related]
14. Treatment of acute idiopathic thrombocytopenic purpura with high-dose methylprednisolone and immunoglobulin.
Barrios NJ; Humbert JR; McNeil J
Acta Haematol; 1993; 89(1):6-9. PubMed ID: 8480491
[TBL] [Abstract][Full Text] [Related]
15. Oral megadose methylprednisolone versus intravenous immunoglobulin for acute childhood idiopathic thrombocytopenic purpura.
Ozsoylu S; Sayli TR; Oztürk G
Pediatr Hematol Oncol; 1993; 10(4):317-21. PubMed ID: 8292515
[TBL] [Abstract][Full Text] [Related]
16. Cytokine Profile, Apoptosis, Glucocorticoid Receptor, and P-glycoprotein Expression Before and After Megadose Methylprednisolone Treatment in Children With Acute Immune Thrombocytopenia.
Yalinbaş EE; Sezgin Evim M; Bör Ö; Gülbaş Z
J Pediatr Hematol Oncol; 2019 Oct; 41(7):574-578. PubMed ID: 30499912
[TBL] [Abstract][Full Text] [Related]
17. The clinical outcome of 260 pediatric ITP patients in one center.
Akbayram S; Dogan M; Ustyol L; Akgun C; Peker E; Bilici S; Caksen H; Oner AF
Clin Appl Thromb Hemost; 2011; 17(6):E30-5. PubMed ID: 20713486
[TBL] [Abstract][Full Text] [Related]
18. [Detection of soluble interleukin-2 receptor in idiopathic thrombocytopenic purpura].
Nomura S; Suzuki M; Miyake T; Miyazaki Y; Kido H; Kagawa H; Yanabu M; Fukuhara S
Nihon Rinsho Meneki Gakkai Kaishi; 1995 Feb; 18(1):14-9. PubMed ID: 7553034
[TBL] [Abstract][Full Text] [Related]
19. Comparison of anti-D immunoglobulin, methylprednisolone, or intravenous immunoglobulin therapy in newly diagnosed pediatric immune thrombocytopenic purpura.
Celik M; Bulbul A; Aydogan G; Tugcu D; Can E; Uslu S; Dursun M
J Thromb Thrombolysis; 2013 Feb; 35(2):228-33. PubMed ID: 22956408
[TBL] [Abstract][Full Text] [Related]
20. Late side effects of high-dose steroid therapy on skeletal system in children with idiopathic thrombocytopenic purpura.
Yildirim ZK; Büyükavci M; Eren S; Orbak Z; Sahin A; Karakelleoğlu C
J Pediatr Hematol Oncol; 2008 Oct; 30(10):749-53. PubMed ID: 19011472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
